You are here

WPD Pharmaceuticals Inc.

WPD Pharmaceuticals Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
WBIO
CSE Index: 
Currency: 

WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

You are here

WPD Pharmaceuticals Inc. (WBIO)

SEDAR Information

Company Info

Address
750 West Pender Street, Suite 401
Vancouver, BC V6C 2T7
Canada
Phone
604-561-2687
Fax
604-565-3332
Email
michael.malana@wpdpharmaceuticals.com
Listing date
Friday, December 27, 2019
Transfer Agent
Computershare Investor Services Inc.

Capitalization

Issued & Outstanding: 
115987137
Reserved for Issuance: 
3949997

Bulletins

24/05/2024

2024-0524 - Reinstatement - WPD Pharmaceuticals Inc. (WBIO)

le 24 mai/May 2024

Effective immediately, WPD Pharmaceuticals Inc. will be reinstated for trading.

The Company has rectified the situation that gave rise to the suspension.

____________________________

Avec effet immédiat, WPD Pharmaceuticals Inc. sera réintégrée à la négociation.

La Société a rectifié la situation qui a donné lieu à la suspension.